Targeting the Immune System in Breast Cancer: Hype or Hope?: TILs and Newer Immune-Based Therapies Being Evaluated for HER2+ and TNBC
Crossref DOI link: https://doi.org/10.1007/s12609-015-0193-0
Published Online: 2015-09-30
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Loibl, Sibylle
Furlanetto, Jenny
Text and Data Mining valid from 2015-09-30